Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAMBIA safely and effectively. See full prescribing information for CAMBIA. CAMBIA® (diclofenac potassium), for oral solution Initial U.S. Approval: 1988
Medication labelWhy this: Advisory · dailymed-prescription
CAMBIA is indicated for the acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Limitations of Use: CAMBIA is not indicated for the prophylactic therapy of migraine. The safety and effectiveness of CAMBIA have not been established for cluster headache, which is present in an older, predominantly male population.
- generic_name
- diclofenac potassium
- product_names
- diclofenac potassium
- ndc
- 13913-012, 13913-012-01, 13913-012-03, 13913-012-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en